Obstetrics & Gynecology, Gynecologic Oncology · Providence, RI
NPI
1790943314
Since 2008
Specialty
Obstetrics & Gynecology, Gynecologic Oncology
Code 207VX0201X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
101 Dudley St
Providence, RI, 02905
Phone (401) 274-1100
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
361 services
Medicare patients, 2024
135
Average age 73
Drug cost, 2024
$1.5M
368 prescriptions
Company payments, 2025
$234
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laura L Holman was code 99215 (office e&m - established), 83 times for 43 patients. In total Laura L Holman billed 361 services in 48 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 83 | 43 | $102.87 | $8,538 |
| 99232 Hospital E&M - Subsequent | Facility | 53 | 28 | $58.72 | $3,112 |
| 99213 Office E&M - Established | Office | 47 | 32 | $44.83 | $2,107 |
| 99204 Office E&M - New | Office | 37 | 37 | $96.49 | $3,570 |
| 99214 Office E&M - Established | Office | 16 | 14 | $63.20 | $1,011 |
By year: 2022 $80K for 697 services; 2023 $59K for 471 services; 2024 $49K for 361 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laura L Holman prescribed most often to Medicare patients was Ondansetron Hcl, with 36 prescriptions and refills. In total Laura L Holman wrote 368 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Generic | 36 | 36 | 26 | $304 |
| Zejula Niraparib Tosylate | 35 | 35 | Under 11 | $616K |
| Prochlorperazine Maleate Generic | 29 | 29 | 24 | $351 |
| Gabapentin Generic | 27 | 27 | Under 11 | $174 |
| Letrozole Generic | 25 | 41 | Under 11 | $4,346 |
| Lenvima Lenvatinib Mesylate | 25 | 25 | Under 11 | $568K |
| Eliquis Apixaban | 14 | 28 | Under 11 | $16K |
| Megestrol Acetate Generic | 14 | 17 | Under 11 | $625 |
| Tamoxifen Citrate Generic | 12 | 15 | Under 11 | $295 |
| Everolimus Generic | 11 | 11 | Under 11 | $60K |
| Levothyroxine Sodium Generic | 11 | 24 | Under 11 | $85.05 |
Brand drugs: 111 claims; generic drugs: 257 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laura L Holman $234 ($234 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $88.2.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.